The Q-Collar and the MilitaryIan Nichols @ 2020-05-12 10:49:23 -0400
Q30 Innovations, the company responsible for the development of the Q-Collar, recently announced a partnership with the U.S. Army Medical Materiel Development Activity (USAMMDA) to study the Q-Collar for the potential to be used by U.S. Service Members that may be at risk of traumatic brain injury as a result of blast waves. As part of this study, Q30 and USAMMDA have agreed to explore the potential applicability for the Q-Collar to be used in military training and environments.
"Our fighting men and women deserve innovative new tools to confront the next generation of threats and reduce the risk of traumatic brain injuries on the battlefield. Q30 Innovations is honored to partner with USAMMDA in the quest to find a solution and protect service members today and for their futures," said Tom Hoey, Co-Founder and Co-CEO of Q30. "We are committed to meeting this challenge and focused on conducting independent and comprehensive, medical and scientific research to test the capabilities of the Q-Collar and demonstrate its ability to protect the brain."
To date, there has been preliminary research completed in regard to the Q-Collar technology and blast scenarios, a prevalent occurrence in US Military operations and training, including a study performed at the Naval Medical Research Center and a study involving paramilitary/SWAT personnel in Cincinnati. The data suggests that the Q-Collar has potential to help protect the brain from a blast-induced traumatic brain injury (bTBI).
Military-related studies build on the significant research already conducted on the Q-Collar in sports. To date, there have been extensive clinical trials with male and female athletes that show that the Q-Collar helps protect the brain from damage caused by sports-related impacts. On the strength of this research, the Q-Collar is currently approved for sale in Canada and available to athletes looking for an added layer of protection against repeated sports related impacts. Additionally, Q30 recently submitted a request to the U.S. Food and Drug Administration, seeking authorization to market the Q-Collar in the United States.
Q30’s mission is to reduce the incidence of traumatic brain injury on the sports field and battlefield. This new research partnership with the US Army, in addition to the Q-Collar’s progress in the sports world, is an important step in achieving this goal.